Dexamethasone/Pancreatic Clamp P&F
Public ClinicalTrials.gov record NCT06126354. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Role of Hyperinsulinemia in NAFLD: Dexamethasone-Pancreatic Clamp Pilot & Feasibility Study
Study identification
- NCT ID
- NCT06126354
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Columbia University
- Other
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Insulin human Drug
- Octreotide Acetate Drug
- Glucagon Drug
- Human Growth Hormone Drug
- Dexamethasone Oral Drug
- [6,6-2H2] D-glucose Other
- 20% D-glucose (aq) Drug
- BOOST Plus Dietary Supplement
- Harvard Apparatus PHD ULTRA CP syringe pump Device
- Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer Device
- Normal saline Other
- Human albumin Other
Drug · Other · Dietary Supplement + 1 more
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2024
- Primary completion
- Nov 29, 2025
- Completion
- Mar 30, 2026
- Last update posted
- Jul 9, 2024
2024 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Columbia University Irving Medical Center | New York | New York | 10032 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06126354, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 9, 2024 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06126354 live on ClinicalTrials.gov.